Anika Therapeutics's total assets for Q1 2025 were $190.60M, a decrease of -5.99% from the previous quarter. ANIK total liabilities were $42.21M for the fiscal quarter, a -13.42% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.